VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Novoron Bioscience

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS).

Also known as Novoron at the BioLabs Campus

  • Biotech & therapeutics
Business model
B2B
Legal name
Novoron at the BioLabs Campus
Claim, correct or request removal

Record updated 29 September 2026

About

Novoron Bioscience is pioneering a proactive approach to treating brain diseases by protecting the vital communication links between brain cells before damage occurs. By engineering a new class of therapies that act as a molecular firewall, the company quarantines toxic proteins to break the transmission chain of cognitive decline and preserve healthy neurons.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy